CYP2C9 c.1080C>G c.1075A>C

CYP2C9 c.1080C>G c.1075A>C

The CYP2C9 c.1080C>G c.1075A>C Novallele Genotyping Assay detects and distinguishes between both the CYP2C9 c.1080C>G and CYP2C9 c.1075A>C mutations of the CYP2C9 gene. Mutations of the CYP2C9 gene inhibit the effectiveness of anticoagulant medication, such as warfarin. Inhibited warfarin metabolism may be characterized by bleeding tendency and thromboembolic diseases, such as pulmonary embolism and stroke.

£177.00

Get in touch

Get in touch with the team

  • :

Product Description

The CYP2C9 c.1080C>G c.1075A>C Novallele Genotyping Assay is used to amplify and identify specific genetic polymorphisms or mutations. This assay provides scientists with a simple way to quickly genotype this locus from isolated human genomic DNA. The assay contains functionally-verified oligonucleotide primers and unlabeled probes necessary for PCR and subsequent allele identification by DNA melting. For Research Use Only. Not for use in diagnostic procedures.